Researchers evaluated the association between diarrheagenic E coli and development of reactive arthritis and musculoskeletal symptoms among international travelers.
Extended-pulsed fidaxomicin regimen for treatment of C difficile infection maintained fidaxomicin stool concentrations above the minimum inhibitory concentration required to inhibit the growth of 90% of organisms for 26 days.
A subset of patients with coronavirus disease 2019 (COVID-19) may present with low disease severity marked only by digestive symptoms.
There remains considerable uncertainty on whether antibiotic prophylaxis for spontaneous bacterial peritonitis is beneficial in people with liver cirrhosis.
From 2011 to 2017, there was a decrease in the estimated national burden of Clostridium difficile infection.
Study shows ST-167, ST-940, and the isolate with an unidentifiable sequence type were cultured from blood and carried the blaNDM-5 gene, conferring phenotypic carbapenem resistance.
A network of gut bacteria species may be associated with host genetic factors that increase susceptibility to multiple sclerosis.
Features of fecal microbiota at baseline and after antibiotic therapy may be predictive of recurrent Clostridiodes difficile infection in patients with and without ulcerative colitis.
The increase in incidence of T1DM may not be solely a result of genetics and environmental factors, but also that of gut microbiota.
Dual therapy with vonoprazan and low-dose amoxicillin had similar efficacy to triple-drug treatment for the eradication of Helicobacter pylori.
